Cite Filings / CGEM / 0000950170-22-016258

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

Cullinan Therapeutics, Inc. Filed 2022-08-10 Acc 0000950170-22-016258

Documents 1

10-Q Quarterly Report , cgem-20220630.htm

Around this filing

2022-11-14 10-Q Quarterly Report
2022-08-16 3 Initial Statement of Ownership
2022-08-10 8-K Results of operations
2022-08-10 10-Q Quarterly Report
2022-08-09 4 Chief Development Officer sold 1,385 shares at $15.01 ($20,789)
2022-08-04 4 10% owner sold 49,910 shares at an average $14.26 ($711,676)
2022-05-16 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading cgem-20220630.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…